Market Tracker

10/23 12:31pm ET

Nymox Pharmaceutical Corp (NASDAQ:NYMX)

5.01
Real-Time Quote
 +0.05 / +1.01%
Today’s Change
3.81
Today|||52-Week Range
7.73
-17.46%
Year-to-Date
No recent news for Nymox Pharmaceutical Corp.

Today’s Trading

Previous close4.96
Today’s open4.91
Day’s range4.91 - 5.05
Volume12,032
Average volume (3 months)92,675
Market cap$175.6M
Dividend yield--
Data as of 12:02pm ET, 10/23/2014

Growth & Valuation

Earnings growth (last year)+39.13%
Earnings growth (this year)-14.29%
Earnings growth (next 5 years)--
Revenue growth (last year)+9.32%
P/E ratioNM
Price/Sales61.71
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CARACara Therapeutics In...+0.27+3.48%
THLDThreshold Pharmaceut...+0.04+1.34%
OHRPOHR Pharmaceutical I...+0.08+1.14%
ARGSArgos Therapeutics I...+0.11+1.24%
Data as of 12:12pm ET, 10/23/2014

Financials

Next reporting dateNovember 14, 2014
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$3.4M
Annual profit (last year)-$4.9M
Net profit margin-146.13%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Paul Averback
Chief Financial Officer
André Monette
Corporate headquarters
Saint-Laurent, Quebec

Forecasts